Article
A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease.
Life sciences - 1 Jun 2023
Ganesan Raja, Gupta Haripriya, Jeong Jin-Ju, Sharma Satya Priya, Won Sung-Min, Oh Ki-Kwang, Yoon Sang Jun, Kim Dong Joon, Suk Ki Tae
Abstract excerpt
AIMS: Nonalcoholic fatty liver disease (NAFLD) is becoming more common and severe. Individuals with NAFLD have an altered composition of gut- microbial metabolites. We used metabolomics profiling to identify microbial metabolites that could indicate gut-liver metabolic severity. Noninvasive biomarkers are required for NAFLD, especially for patients at high risk of disease progression. MAIN METHODS: We compared...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.